Quick Takeaways
- HAE - HAEMONETICS CORP has 23 insiders with reported activity on this page.
- Net insider value flow over the last year: +$98,784.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 23 Insiders of HAEMONETICS CORP
- Symbol
- HAE on NYSE
- Location
- Boston, MA
What Changed
- Buy value: $98,784; sell value: $0.
- Net share flow: +1,400.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$98,784.
Buys
$98,784
Shares: 1,400
Insiders: 1
Sells
$0
Shares: 0
Insiders: 0
Net
+$98,784
Shares: +1,400
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 1,400 | 0 | $98,784 | $0 | +$98,784 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
HAEMONETICS CORP executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Christopher Simon | President & CEO, Director | $26,055,242 | Mixed | 30 May 2025 | ||
| Josep Llorens | EVP, Global Manufacturing | $2,961,886 | Mixed | 28 May 2024 | ||
| William P. Mr. Burke | EVP, Chief Financial Officer | $2,616,839 | Mixed | 23 Aug 2021 | ||
| Michelle L. Basil | EVP and General Counsel | $2,201,710 | Mixed | 30 May 2025 | ||
| James Darecca | EVP, Chief Financial Officer | $1,962,898 | Mixed | 30 May 2025 | ||
| Anila Lingamneni | EVP, Chief Technology Officer | $1,919,790 | Filing P/S | 11 Jul 2024 | ||
| Charles J. Dockendorff | Director | $1,868,308 | Mixed | 24 Jul 2025 | ||
| Robert E. Abernathy | Director | $1,863,832 | Mixed | 24 Jul 2025 | ||
| Mark W. Kroll | Director | $1,746,853 | +$98,784 | +6% | Filing P/S | 10 Nov 2025 |
| Catherine M. Burzik | Director | $1,688,493 | Mixed | 05 Aug 2022 | ||
| Stewart W. Strong | President, Global Hospital | $1,658,565 | Filing P/S | 26 Jul 2024 | ||
| Chad M. Nikel | President, Global Plasma & BC | $1,497,657 | Mixed | 06 Aug 2021 | ||
| Ellen M. Zane | Director | $1,445,419 | Mixed | 24 Jul 2025 | ||
| Laurie A. Miller | SVP, Human Resources | $1,444,803 | Mixed | 17 Sep 2025 | ||
| Claire Pomeroy | Director | $1,258,819 | Mixed | 24 Jul 2025 | ||
| Michael J. Coyle | Director | $1,148,546 | Mixed | 24 Jul 2025 | ||
| Lloyd E. Johnson | Director | $964,931 | Mixed | 24 Jul 2025 | ||
| Roy Galvin | EVP, Chief Commercial Officer | $640,678 | Mixed | 31 Oct 2025 | ||
| Diane M. Bryant | Director | $531,670 | Mixed | 24 Jul 2025 | ||
| Dan Goldstein | VP, Corporate Controller | $384,176 | Mixed | 13 Jun 2022 | ||
| Jacqueline Scanlan | SVP, Global Human Resources | $364,220 | Mixed | 07 Jun 2021 | ||
| Frank Chan | EVP, Chief Operating Officer | $352,262 | Mixed | 16 May 2025 | ||
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | $279,830 | Mixed | 05 Jun 2025 |
Top shareholders of HAEMONETICS CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
13%
|
5,820,954
|
$466,549,479 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
4,761,135
|
$381,604,971 | — | 31 Dec 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
8.3%
|
3,865,676
|
$309,882,554 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
6.8%
from 13D/G
|
3,163,104
|
$253,522,786 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
4.6%
|
2,203,351
|
$165,537,761 | -$36,448,193 | 30 Jun 2025 | |
| North Peak Capital Management, LLC |
13D/G
13F
|
Company |
5.1%
|
2,370,495
|
$154,129,585 | $0 | 24 Feb 2026 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
1,729,847
|
$138,647,237 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
4.4%
|
2,195,569
|
$135,949,632 | $0 | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
3%
|
1,380,102
|
$110,615,175 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
2.9%
|
1,326,902
|
$106,351,232 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.8%
|
1,288,432
|
$103,267,825 | — | 31 Dec 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
2.7%
|
1,264,271
|
$101,331,321 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.6%
|
1,226,614
|
$98,313,113 | — | 31 Dec 2025 | |
| Capital Research Global Investors |
13D/G
|
— |
3.1%
|
1,577,323
|
$97,667,840 | $0 | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
1,194,551
|
$95,758,176 | — | 31 Dec 2025 | |
| River Road Asset Management, LLC |
13F
|
Company |
2.4%
|
1,102,140
|
$88,336,521 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.4%
|
1,092,938
|
$87,602,682 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
2.1%
|
967,593
|
$77,553,000 | — | 31 Dec 2025 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
2%
|
939,727
|
$75,159,365 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
853,379
|
$68,398,327 | — | 31 Dec 2025 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
1.5%
|
716,997
|
$57,467,310 | — | 31 Dec 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.2%
|
580,650
|
$46,539,097 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
577,728
|
$46,304,898 | — | 31 Dec 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.2%
|
573,653
|
$45,978,539 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
1.2%
|
569,173
|
$45,619,216 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
562,949
|
$45,120,430 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
548,921
|
$43,996,018 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
539,677
|
$43,255,111 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.1%
|
526,287
|
$42,181,902 | — | 31 Dec 2025 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
1.1%
|
523,113
|
$41,927,507 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
482,165
|
$38,645,525 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1%
|
464,104
|
$37,197,965 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.93%
|
432,955
|
$34,701,345 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.86%
|
401,758
|
$32,200,904 | — | 31 Dec 2025 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
0.8%
|
370,308
|
$29,680,193 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
359,190
|
$28,790,000 | — | 31 Dec 2025 | |
| Christopher Simon |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
421,886
mixed-class rows
|
$26,055,242 | — | 30 May 2025 | |
| Boston Partners |
13F
|
Company |
0.69%
|
322,667
|
$25,774,881 | — | 31 Dec 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
314,654
|
$25,219,518 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.66%
|
305,215
|
$24,462,947 | — | 31 Dec 2025 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.6%
|
278,314
|
$22,306,867 | — | 31 Dec 2025 | |
| LONDON CO OF VIRGINIA |
13F
|
Company |
0.57%
|
263,565
|
$21,125,001 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.55%
|
256,553
|
$20,562,723 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.5%
|
234,575
|
$18,801,186 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.4%
|
186,719
|
$14,965,191 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.36%
|
168,725
|
$13,523,308 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.36%
|
168,323
|
$13,491,087 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.36%
|
167,356
|
$13,413,192 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.35%
|
163,779
|
$13,126,888 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.33%
|
154,247
|
$12,362,897 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for HAEMONETICS CORP
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark W. Kroll | HAE | Common Stock | Purchase | 5.99% | $98,784 | $70.56 | 1,400 | 24,757 | 10 Nov 2025 | Direct |
| Roy Galvin | HAE | Common Stock | Tax liability | -1.12% | -145 | 12,811 | 31 Oct 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -0.82% | -238 | 28,925 | 17 Sep 2025 | Direct | ||
| Ellen M. Zane | HAE | Common Stock | Award | 16.2% | 2,693 | 19,373 | 24 Jul 2025 | Direct | ||
| Claire Pomeroy | HAE | Common Stock | Award | 19% | 2,693 | 16,872 | 24 Jul 2025 | Direct | ||
| Mark W. Kroll | HAE | Common Stock | Award | 13% | 2,693 | 23,357 | 24 Jul 2025 | Direct | ||
| Lloyd Emerson Johnson | HAE | Common Stock | Award | 26.3% | 2,693 | 12,933 | 24 Jul 2025 | Direct | ||
| Charles J. Dockendorff | HAE | Common Stock | Award | 60.8% | 2,693 | 7,126 | 24 Jul 2025 | Direct | ||
| Michael J. Coyle | HAE | Common Stock | Award | 21.2% | 2,693 | 15,394 | 24 Jul 2025 | Direct | ||
| Diane M. Bryant | HAE | Common Stock | Award | 60.8% | 2,693 | 7,126 | 24 Jul 2025 | Direct | ||
| Robert E. Abernathy | HAE | Common Stock | Award | 12.1% | 2,693 | 24,981 | 24 Jul 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Award | 12.3% | 3,195 | 29,163 | 05 Jun 2025 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Award | 146.6% | 2,662 | 4,478 | 05 Jun 2025 | Direct | ||
| Christopher Simon | HAE | Common Stock | Tax liability | -6.53% | -26,234 | 375,544 | 30 May 2025 | Direct | ||
| Christopher Simon | HAE | Common Stock | Award | 19.9% | 66,666 | 401,778 | 30 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -8.08% | -2,283 | 25,968 | 30 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Award | 38% | 7,777 | 28,251 | 30 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -17.2% | -5,864 | 28,292 | 30 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Award | 55.7% | 12,221 | 34,156 | 30 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Tax liability | -15% | -7,469 | 42,252 | 30 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Award | 45.5% | 15,554 | 49,721 | 30 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Award | 23.7% | 6,755 | 35,233 | 16 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Non-qualified Stock Option (Right to Buy) | Award | 14,626 | 14,626 | 16 May 2025 | Direct | |||
| Roy Galvin | HAE | Common Stock | Award | 78.5% | 5,689 | 12,932 | 16 May 2025 | Direct | ||
| Roy Galvin | HAE | Non-qualified Stock Option (Right to Buy) | Award | 12,317 | 12,317 | 16 May 2025 | Direct | |||
| Farris Maryanne Maunsell | HAE | Common Stock | Award | 78.7% | 800 | 1,816 | 16 May 2025 | Direct | ||
| Farris Maryanne Maunsell | HAE | Non-qualified Stock Option (Right to Buy) | Award | 1,732 | 1,732 | 16 May 2025 | Direct | |||
| Laurie A. Miller | HAE | Common Stock | Award | 18.5% | 3,200 | 20,474 | 16 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Non-qualified Stock Option (Right to Buy) | Award | 6,928 | 6,928 | 16 May 2025 | Direct | |||
| Frank Chan | HAE | Common Stock | Award | 5,689 | 5,689 | 16 May 2025 | Direct | |||
| Frank Chan | HAE | Non-qualified Stock Option (Right to Buy) | Award | 12,317 | 12,317 | 16 May 2025 | Direct | |||
| James Darecca | HAE | Common Stock | Award | 48% | 7,111 | 21,935 | 16 May 2025 | Direct | ||
| James Darecca | HAE | Non-qualified Stock Option (Right to Buy) | Award | 15,396 | 15,396 | 16 May 2025 | Direct | |||
| Christopher Simon | HAE | Common Stock | Award | 6.82% | 21,405 | 335,112 | 16 May 2025 | Direct | ||
| Christopher Simon | HAE | Non-qualified Stock Option (Right to Buy) | Award | 46,342 | 46,342 | 16 May 2025 | Direct | |||
| Michelle L. Basil | HAE | Common Stock | Tax liability | -7.04% | -2,157 | 28,478 | 16 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -7.75% | -1,246 | 14,824 | 16 May 2025 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Tax liability | -6.27% | -68 | 1,016 | 16 May 2025 | Direct | ||
| Roy Galvin | HAE | Common Stock | Tax liability | -3.43% | -257 | 7,243 | 16 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -2.69% | -477 | 17,274 | 16 May 2025 | Direct | ||
| Christopher Simon | HAE | Common Stock | Tax liability | -2.21% | -7,089 | 313,707 | 16 May 2025 | Direct | ||
| Michelle L. Basil | HAE | Common Stock | Tax liability | -1.99% | -622 | 30,635 | 15 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -3.73% | -622 | 16,070 | 15 May 2025 | Direct | ||
| Farris Maryanne Maunsell | HAE | Common Stock | Tax liability | -5.24% | -60 | 1,084 | 15 May 2025 | Direct | ||
| Roy Galvin | HAE | Common Stock | Tax liability | -2.61% | -201 | 7,500 | 15 May 2025 | Direct | ||
| Laurie A. Miller | HAE | Common Stock | Tax liability | -1.15% | -206 | 17,751 | 15 May 2025 | Direct | ||
| Christopher Simon | HAE | Common Stock | Tax liability | -0.74% | -2,391 | 320,796 | 15 May 2025 | Direct | ||
| James Darecca | HAE | Common Stock | Tax liability | -3.77% | -654 | 16,692 | 02 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.